BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2439229)

  • 1. Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart.
    Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
    Circ Res; 1987 May; 60(5):666-73. PubMed ID: 2439229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.
    Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):619-24. PubMed ID: 2831348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion.
    Simpson PJ; Fantone JC; Mickelson JK; Gallagher KP; Lucchesi BR
    Circ Res; 1988 Dec; 63(6):1070-9. PubMed ID: 2461814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion.
    Chiariello M; Golino P; Cappelli-Bigazzi M; Ambrosio G; Tritto I; Salvatore M
    Am Heart J; 1988 Mar; 115(3):499-504. PubMed ID: 2449815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of iloprost in the stunned canine myocardium.
    Farber NE; Pieper GM; Thomas JP; Gross GJ
    Circ Res; 1988 Feb; 62(2):204-15. PubMed ID: 2448057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
    Mizumura T; Nithipatikom K; Gross GJ
    Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitation of myocardial infarct size in pigs with a dual lipoxygenase-cyclooxygenase blocking agent by inhibition of neutrophil activity without reduction of neutrophil migration.
    Amsterdam EA; Pan HL; Rendig SV; Symons JD; Fletcher MP; Longhurst JC
    J Am Coll Cardiol; 1993 Nov; 22(6):1738-44. PubMed ID: 8227848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation.
    Simpson PJ; Mitsos SE; Ventura A; Gallagher KP; Fantone JC; Abrams GD; Schork MA; Lucchesi BR
    Am Heart J; 1987 Jan; 113(1):129-37. PubMed ID: 3541554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
    Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
    Auchampach JA; Pieper GM; Cavero I; Gross GJ
    Basic Res Cardiol; 1998 Oct; 93(5):361-71. PubMed ID: 9833148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion.
    Forman MB; Pitarys CJ; Vildibill HD; Lambert TL; Ingram DA; Virmani R; Murray JJ
    J Am Coll Cardiol; 1992 Jan; 19(1):205-16. PubMed ID: 1729335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and late administration of a PGI2-analogue, ZK 36 374 (iloprost): effects on myocardial preservation, collateral blood flow and infarct size.
    Smith EF; Gallenkämper W; Beckmann R; Thomsen T; Mannesmann G; Schrör K
    Cardiovasc Res; 1984 Mar; 18(3):163-73. PubMed ID: 6200229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction.
    Simpson PJ; Schelm JA; Jakubowski JA; Smallwood JK
    J Pharmacol Exp Ther; 1991 Sep; 258(3):979-85. PubMed ID: 1653847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.
    Chi LG; Tamura Y; Hoff PT; Macha M; Gallagher KP; Schork MA; Lucchesi BR
    Circ Res; 1989 Apr; 64(4):665-75. PubMed ID: 2702730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloricromene reduces infarct size and alters postischaemic blood flow defects in dog myocardium.
    Groban L; Zvara DA; Deal DD; Vernon JC; Flye CW; Ma XL; Vinten-Johansen J
    Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):417-23. PubMed ID: 9673816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs.
    Lefer DJ; Nakanishi K; Johnston WE; Vinten-Johansen J
    Circulation; 1993 Nov; 88(5 Pt 1):2337-50. PubMed ID: 8222127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
    Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats.
    Lee YM; Hsiao G; Chen HR; Chen YC; Sheu JR; Yen MH
    Eur J Pharmacol; 2001 Jun; 422(1-3):159-67. PubMed ID: 11430926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
    Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE
    Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function.
    Simpson PJ; Todd RF; Mickelson JK; Fantone JC; Gallagher KP; Lee KA; Tamura Y; Cronin M; Lucchesi BR
    Circulation; 1990 Jan; 81(1):226-37. PubMed ID: 2153476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.